The first enemy Healthcasts fought was not disease. It was the hotel ballroom. In the late 1990s and early 2000s, medical education still moved city by city: reserve a room, bring in a speaker, hope a dozen or two physicians showed up, then repeat the whole expensive production somewhere else. John Theobald, a science graduate who had deferred medical school and built an internet-service business, saw streaming technology mature and spotted the obvious inefficiency. One broadcast could reach tens of thousands of doctors in an evening. The exact dollar saving was never made public; Theobald described it simply as a fraction of the old cost.
That was the original Healthcasts, founded in 2001: a digital video channel for physician education. It soon broadcast hundreds of seminars a year and worked with major pharmaceutical companies. But the more interesting company is the one that emerged after the novelty of streaming wore off. Healthcasts listened to what physicians did, not what a media plan presumed they ought to do. Scheduled broadcasts gave way to on-demand programs. Video expanded into interactive material. Education became consultation. By 2023, an AI layer was summarizing peer exchanges. Today the pitch is no longer “watch this medical program.” It is “search what other verified clinicians actually did.”
01 / The useful mess
Where guidelines stop being tidy
Clinical guidelines are built to be general. Patients are spectacularly uncooperative with that format. They arrive with two conditions, three drugs, an allergy, an insurance denial and a side effect that barely appeared in a trial. A family physician may be wandering beyond a familiar specialty. A rural clinician may not have the right colleague down the hall. A new therapy may be moving faster than the document meant to explain it.
Healthcasts treats that gap as its raw material. U.S. physicians, nurse practitioners and physician associates with valid National Provider Identifier numbers can join at no charge. Members post a clinical question or patient scenario, reply to peers and search more than 600,000 archived consultations by disease or treatment. Specialty feeds keep the stream relevant, while cross-specialty views make it possible to see cardiology beside oncology, dermatology beside gastroenterology. The network is private to logged-in professionals; public visitors do not get the consultations.
The product’s small but important trick is compression. A busy doctor does not necessarily need 80 comments. Consensus Summaries distill the broad agreement, and the ConsensusMD research tool surfaces related treatments, frequently mentioned practical details and the consults most responsive to a query. That includes the untidy information clinicians care about: dosing, side effects, administration, affordability, comorbidities and off-label experience. It is a map of practice, not a replacement for evidence.
“Medicine advances when clinicians share what they actually do, not just what the guidelines say.”Healthcasts’ stated belief
02 / The pivot
What failed first was the calendar
There is no public account of a catastrophic Healthcasts flop. The documented failure was more ordinary and more useful: the old format stopped matching physicians’ lives. Local seminars were slow and costly to repeat. Scheduled digital broadcasts solved reach but still demanded that clinicians be present at a particular time. Healthcasts moved on-demand because, Theobald said in 2014, it better suited members. Later, physician feedback pushed the company beyond video into interactive “challenges,” short snippets and other formats.
This is the decision that founders can copy. Healthcasts did not confuse its first delivery mechanism with its mission. The mission was physician education; television and web video were simply the best pipes available in 2001. Once the audience began producing useful answers of its own, the company could turn those exchanges into the product. Its strongest asset became less like a studio library and more like a structured memory of clinical practice.
By 2016, PM360 reported that Healthcasts served more than 106,000 physicians, offered 1.3 million programs across more than 30 specialties and worked with more than 30 educational partners. The publication named Theobald an ELITE Master Educator that year. Those figures describe an earlier incarnation, not the current active-user count, but they explain how Healthcasts accumulated the relationships and behavior data needed for its next move.
03 / AI with house rules
The model summarizes. The doctors remain the point.
ConsensusAI arrived in July 2023 with a carefully bounded job: analyze hundreds of thousands of consultations and turn them into immediate, organized insight. A 2024 update added “Top Related Treatments,” “Frequently Mentioned Insights” and “Most Relevant Consults.” In 2025, a brand overhaul made consensus a visible part of the whole platform. The company now says AI should synthesize clinical insight, not replace it.
That positioning matters because Healthcasts competes in an unruly neighborhood. UpToDate and DynaMed organize published medical evidence. Doximity and Sermo connect doctors. Figure 1 centers case discussion. General AI assistants can generate a smooth answer in seconds. Healthcasts’ claim is narrower: its answers come from a proprietary archive of real exchanges among credentialed practitioners, and its software exposes what peers agree on. The credential gate reduces reach, but gives each contribution provenance.
The weakness is equally clear. Consensus is not automatically correctness. A popular practice can be outdated, biased or simply wrong for the patient in front of the screen. Minority opinions can carry the important warning. Healthcasts works best as a fast second look beside evidence, local policy and professional judgment. It would work poorly as an open consumer symptom checker, outside the U.S. credential system, in a specialty with too few active contributors or anywhere a user treats a summary as an instruction.
04 / Who pays
Free for clinicians, valuable to pharma
Healthcasts is a two-sided business. Verified providers use the peer network without a subscription. The company’s FAQ says they may sometimes be asked to view relevant clinical content from sponsors. On the other side, pharmaceutical and life-sciences customers buy contextual advertising, custom educational modules and analytics. In 2025, Healthcasts expanded those offerings by integrating capabilities from sister company MDcentRx.
The commercial logic is tidy: a clinician researching a specific treatment question is more relevant to a life-sciences brand than a broad audience scrolling a generic feed. Healthcasts can place approved material beside the moment of inquiry, build interactive modules around trial data and report what topics practitioners are exploring. The supplied company record estimates annual revenue at about $40.7 million, but Healthcasts is private and does not publicly confirm that figure. No disclosed funding rounds or valuation surfaced in the public record.
The tension is not tidy. Sponsor money can keep peer knowledge free; it can also make practitioners wonder where education ends and promotion begins. The model depends on bright lines: clear labels, independent peer discussion, protected member trust and a product useful enough that clinicians would return even when no ad is present. Lose that trust and the archive becomes a marketing channel wearing a stethoscope.
What to steal
Verify members, capture questions inside the workflow, turn repeated answers into searchable memory, compress without erasing nuance, and charge the commercial side for relevance.
When it breaks
Thin participation, weak moderation, sponsor influence, international credential mismatch or users mistaking peer consensus for patient-specific medical direction.
05 / The market
A professional network with a memory
Healthcasts sits at the overlap of medical media, clinician social networks, decision support, continuing education and HCP marketing. That sounds sprawling because it is. Yet the pieces share one scarce input: verified attention at the point of care. The company’s culture statement - practical experience over generic summaries, clinicians guiding content rather than editors - also explains the product architecture. A post is social content today, a search result tomorrow, a consensus data point later and a context signal for a commercial campaign.
The sequence is worth noticing. Healthcasts earned distribution before it attempted synthesis. It spent years learning which specialties wanted depth, which generalists wanted breadth and which formats fit between patients. A new entrant can copy the sequence, but not skip it. Without enough credible exchanges, a consensus engine merely summarizes scarcity. Without a narrow professional identity, the feed drifts toward generic advice. And without a reason for contributors to return, the most polished search box is just an empty waiting room.
The durable lesson is not “add AI.” It is almost the reverse. Spend years earning a community’s participation. Observe the questions that recur. Build structure around the answers. Then use AI for the clerical work of retrieval and synthesis, while leaving the accountable decision with the professional. Healthcasts has changed formats repeatedly because the format was never the real business. The real business is making one clinician’s hard-won experience useful to the next clinician before the hallway conversation is too late.